中华医学会骨质疏松和骨矿盐疾病分会2017
原发性骨质疏松症诊疗指南(2017)
中华骨质疏松和骨矿盐疾病杂志, 10(5), 413-443(表 10 抗骨质疏松症药物治疗适应证
Wells GA, Hsieh SC, Peterson J, et al2025
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
Cochrane Database of Systematic Reviews
查看原文 ↗Lyles KW, Colón-Emeric CS, Magaziner JS, et al2007
Zoledronic acid and clinical fractures and mortality after hip fracture
New England Journal of Medicine
查看原文 ↗Cummings SR, Lui LY, Eastell R, Allen IE2019
Association Between Drug Treatments for Patients With Osteoporosis and Overall Mortality Rates: A Meta-analysis
JAMA Internal Medicine
查看原文 ↗Kahwati LC, Kistler CE, Booth G, et al2025
Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the US Preventive Services Task Force
JAMA
查看原文 ↗Wang L, Yu W, Yin X, et al2021
Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study
JAMA Network Open
查看原文 ↗